Google's Unreliable Claims Rule for Diet Offers

what does google's unreliable claims policy actually prohibit?

Google's Unreliable claims policy prohibits advertising an outcome that most buyers would not expect from ordinary use, whether or not that outcome is achievable at all, and answering that question correctly is the core google ads weight loss policy problem a diet advertiser has to solve before writing a single headline. The clause lives inside Google's broader Misrepresentation rule, the same policy family that also covers clickbait ads and false business claims, and we checked it directly against Google's own page rather than the shorthand that circulates among media buyers. Google names the violation in exact terms, calling out 'claims that entice the user with an improbable result (even if this result is possible) as the likely outcome a user can expect,' according to Google's Ads Policy on Misrepresentation.

Possibility is not the test.

That standard reaches ad text, headlines, landing-page copy and the images sitting next to them, anywhere Google's reviewers can read intent into a promised result. The rule doesn't require you to prove your product never worked; it requires you to describe the outcome a typical buyer would reasonably expect, not the best result your best customer ever posted.

which weight loss example does google publish in the policy text?

Google publishes exactly one weight-loss example in the unreliable claims text, and it stacks two failure modes into a single sentence: a time-frame promise and a no-effort promise. Google's own line reads, 'A weight loss ad that says you can eat whatever you want and lose 10 pounds in a month.'

The example works because it isolates the effort variable from the outcome variable. Google's broader text bans 'making claims of unrealistic weight loss within a specific time frame or requiring little effort,' two separate triggers joined by 'or,' meaning either one alone is enough to violate the clause, and the eat-whatever-you-want line hits both at once. If your headline matches that shape even loosely, expect a rejection rather than a warning.

what makes a result 'improbable' rather than merely optimistic?

A result becomes 'improbable' under Google's test the moment a typical buyer would expect it as the normal outcome, regardless of whether one buyer, somewhere, actually achieved it. That's the distinction Google's own parenthetical draws in the clause quoted above: probability of a typical outcome, not truthfulness of an isolated one, is what review checks against.

Probable and true are different tests.

Outside Google's own text, the sharpest anchor for what counts as improbable comes from FTC's Gut Check guide, which defines 'substantial weight loss' as a pound a week for more than four weeks, or more than 15 pounds total, a number Google doesn't publish but that gives you a concrete line to test your own copy against. Treat it as a rule of thumb, not a Google-enforced threshold; Google's reviewers apply case-by-case judgment, and we found no published numeric cutoff on Google's own side.

what does google require behind a guaranteed-results claim?

Google requires an accessible refund policy behind any guaranteed-results claim before that guarantee can run. If your ad or landing page tells a buyer they will get a specific result or their money back, Google expects that refund mechanism to actually exist and be reachable from the ad experience, not buried on a terms page nobody finds.

This requirement sits next to, not inside, the unreliable claims clause. A guarantee can be procedurally compliant on the refund side and still fail the improbable-result test on the claim side, so fixing one doesn't fix the other. Compounded-GLP-1 and Mounjaro-adjacent funnels run into this twice over, since drug-name proximity pulls in a second policy stack entirely; see our reference on Mounjaro weight-loss offers for what changes once a brand name enters the copy.

which disclaimer does google demand on specific-result testimonials?

Google demands a visible disclaimer on any testimonial that claims a specific result, stating plainly that the result isn't guaranteed and that outcomes vary. The exact requirement: 'Testimonials that claim specific results must include a visible disclaimer stating that there is no guarantee of specific results and that the results can vary,' per Google's Ads Policy.

Here's the part most media buyers get wrong: they assume this bar matches FTC's stricter rule, which requires disclosing the actual study average next to a dramatic testimonial rather than a generic variability line. Google's text asks for less. A visible 'results may vary' disclaimer appears to satisfy the letter of Google's testimonial rule even though FTC's own guidance treats that exact phrasing as insufficient to cure a misleading claim, so don't assume your Google-compliant testimonial protects you from an FTC problem too. Treating the two bars as one bar is the mistake we see most often.

how much warning comes before an account suspension?

Google gives you at least 7 days' warning before suspending an account over an ordinary Misrepresentation violation, which is where Unreliable claims sits. That window applies to the ordinary tier of the policy specifically, not to every violation on the Misrepresentation page.

Egregious violations skip the warning entirely.

We could not verify whether that 7-day clock shortens or resets on a second Unreliable claims violation from the same account; Google's published text doesn't say, and confirming it would take a controlled repeat-violation test we haven't run and wouldn't recommend running on a live account.

• Ordinary Misrepresentation violations — Unreliable claims, Clickbait ads, Misleading representation, Unclear relevance — get at least 7 days' notice before suspension
• Egregious violations — Unacceptable business practices, Coordinated deceptive practices — are suspended immediately, without prior warning, per [Google's Misrepresentation policy](https://support.google.com/adspolicy/answer/6020955)

how does the little-effort clause catch metabolism and fat-burner copy?

The little-effort clause catches metabolism and fat-burner copy the same way it catches diet-pill copy: any promise that results arrive with minimal action from the buyer trips it, independent of whether the word 'weight' ever appears. A line like 'fix your metabolism and the weight comes off on its own' is a little-effort claim by construction, whether it's marketed as a supplement, a patch or a drink.

We counted the clause's two triggers again here on purpose: 'a specific time frame' and 'little effort' are separate hooks, and metabolism copy tends to hit the second one even when it avoids the first by never naming a deadline. If you're choosing between a metabolism angle and a straight weight-loss angle before you write copy, our breakdown of which weight-loss angle converts is a reasonable place to start, though the compliance read stays the same either way.

how does this policy differ from meta's approach to the same creative?

Google and Meta regulate the same creative through structurally different mechanisms. Google's rule is a claims test embedded in Misrepresentation, while Meta's Health and Wellness ad standard is a restricted-category policy with its own age gate and imagery rules layered on top. We read the two side by side, and they aim at the same headline without sharing language.

Meta also runs a rule Google has no equivalent for: its personal attributes policy bars second-person health references like 'your diabetes' or 'your weight problem,' covered in Meta's 'you' rule on personal attributes.

For the clause-by-clause read of Meta's own weight-loss standard, see Meta's weight-loss ad rules broken down; the two pages are worth reading together if you're running the same creative on both platforms.

Quick decision checklist

Use this page as a decision aid, not a generic blog post. The practical question is whether the reader needs faster evidence about what is already working in VSL-driven direct response, especially across nutra, supplements, GLP-1, weight loss, blood sugar, and adjacent high-intent health markets.

Daily Intel Service is most relevant when the next decision depends on active market examples: which hook to test, which claim style is risky, which funnel structure is common, which language market is moving, and whether a competitor's creative is likely early, scaling, or already saturated.

• Start with the TL;DR if you need the direct answer.
• Use the table to compare trade-offs quickly.
• Use the FAQ for answer-engine-ready summaries.
• Use the CTA when the decision requires live VSL and ad examples instead of theory.

Daily Intel's coverage advantage

Daily Intel Service is positioned around category-leading variety and actionability: one of the broadest direct-response catalogs of VSLs and ad creatives across blackhat, greyhat, and whitehat advertising patterns, with enough context to understand what the advertiser is doing beyond the visible creative. The practical difference is that members are not just seeing a screenshot; they are seeing the VSL, the ad, the funnel path, the transcript, the UTM context, and the research notes that turn the asset into a decision.

This matters because direct-response affiliates do not operate in one clean category. A weight-loss campaign may use a whitehat compliance ad, a greyhat pre-lander, a more aggressive VSL, and a checkout path designed around upsells and recovery. A useful intelligence platform needs to capture that spectrum instead of pretending every winning campaign looks like a public brand ad.

Blackhat, whitehat, and multilingual signal coverage

Daily Intel tracks patterns across both blackhat-style and whitehat-style campaigns so operators can understand the market without blindly copying risk. Whitehat examples help with durability and compliance review; blackhat and greyhat examples reveal pressure points, hooks, mechanisms, and funnel structures that may be driving spend but require careful adaptation before use.

The catalog is also built for global operators, with VSL and ad references spanning 14+ languages and different local idioms. That is a key advantage for Brazilian, LATAM, European, MENA, Indian, and non-native English affiliates who need to see how the same market desire is translated across cultures instead of only studying US English ads.

How to use the intelligence responsibly

The goal is modeling, not copying. Use Daily Intel to understand structure: hook, mechanism, proof, claim intensity, funnel depth, offer economics, and saturation stage. Then build original creative, review claims, and adapt the angle to the traffic source, country, language, and compliance requirements of the campaign.

A strong workflow compares multiple examples before acting. If the same mechanism appears across several languages, several advertisers, and several funnel variants, it may be a durable market signal. If the example appears only once or depends on an aggressive claim, treat it as a research clue rather than a campaign template.

• Model structure, not protected creative assets.
• Separate whitehat durability from blackhat persuasion pressure.
• Compare US English examples against LATAM, European, and other language variants.
• Use transcripts and funnel notes to build original briefs.
• Keep compliance review separate from market research.

Methodology and source context

Daily Intel pages are written from a research workflow that reviews active VSLs, Meta ad creatives, transcripts, UTMs, funnel paths, checkout steps, upsells, recovery sequences, and compliance-sensitive claim patterns. The goal is to explain observable market behavior, not to provide legal, medical, or platform policy advice.

For external context, readers should compare advertising and research decisions against authoritative primary references such as FTC health claims guidance, Meta advertising standards, and Meta Ad Library. Daily Intel adds the proprietary direct-response layer: blackhat, greyhat, and whitehat campaign pattern comparison across VSL-heavy niches and 14+ language markets.

For deeper evaluation, continue through Nutra niche intelligence directory, Blood Pressure Offers: Market, Buyer, and the Hypertension Line, Cholesterol Offers: The Statin-Adjacent Niche and Its Rules, Varicose Vein and Circulation Offers: Market and Claim Limits, Menopause and Women's Hormone Offers: Market and Rules, and GLP-1 affiliate marketing intelligence. These related Daily Intel pages connect this topic to the relevant methodology, pricing, trust context, comparison path, or niche workflow.